EFTA00718974Set 9
2012-03-132p705w
distributed globally by Abbott, targeting two of the most threatening healthcare-associated
infections, Clostridium dinette, and vancomycin-resistant enterococci. Diagnostic tests for Group B
streptococcus and Influenza
https://www.justice.gov/epstein/files/DataSet%209/EFTA00718974.pdf